Genuv

CompanySouth Korea

Genuv develops one asset, in phase 1, discontinued (SNR1611 in amyotrophic lateral sclerosis). Based in South Korea.

1
Asset
Furthest stage
Phase 1, discontinued
1
Trial
0
Signals

Pipeline

1
  • SNR1611

    Phase 1, discontinued, amyotrophic lateral sclerosis

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials1
  • Similar companies6

Intelligence